Report cover image

Global Biosimilar Monoclonal Antibodies Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532226

Description

Global Biosimilar Monoclonal Antibodies Competitive Landscape Professional Research Report 2025



Research Summary

Biosimilar monoclonal antibodies are therapeutic proteins that are highly similar to existing monoclonal antibodies, which are designed to target specific disease-causing molecules in the body. Biosimilar monoclonal antibodies are created through a complex manufacturing process that involves the use of living cells to produce proteins that mimic the structure and function of the original antibody. These biosimilars undergo rigorous testing to demonstrate similarity in terms of efficacy, safety, and quality compared to the reference monoclonal antibody. They offer the potential for more affordable and accessible treatment options for patients, as they can be approved as alternatives to expensive brand-name monoclonal antibodies once their patents expire.

According to DIResearch's in-depth investigation and research, the global Biosimilar Monoclonal Antibodies market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Biosimilar Monoclonal Antibodies include Biocon, Accord Healthcare, AET Biotech, Amgen, Celltrion, Reddy＇s Laboratories, Hospira, 3SBio, Allergan, Alvartis etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Biosimilar Monoclonal Antibodies. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biosimilar Monoclonal Antibodies market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biosimilar Monoclonal Antibodies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biosimilar Monoclonal Antibodies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Biosimilar Monoclonal Antibodies Include:

Biocon

Accord Healthcare

AET Biotech

Amgen

Celltrion

Reddy＇s Laboratories

Hospira

3SBio

Allergan

Alvartis

Biosimilar Monoclonal Antibodies Product Segment Include:

Limited Dilution Method

Micromanipulation

Soft Agar Plate Method

Others

Biosimilar Monoclonal Antibodies Product Application Include:

Chronic & Autoimmune Diseases

Oncology

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Biosimilar Monoclonal Antibodies Industry PESTEL Analysis

Chapter 3: Global Biosimilar Monoclonal Antibodies Industry Porter’s Five Forces Analysis

Chapter 4: Global Biosimilar Monoclonal Antibodies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Biosimilar Monoclonal Antibodies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Biosimilar Monoclonal Antibodies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Product Definition and Statistical Scope
1.2 Biosimilar Monoclonal Antibodies Product by Type
1.2.1 Limited Dilution Method
1.2.2 Micromanipulation
1.2.3 Soft Agar Plate Method
1.2.4 Others
1.3 Biosimilar Monoclonal Antibodies Product by Application
1.3.1 Chronic & Autoimmune Diseases
1.3.2 Oncology
1.3.3 Others
1.4 Global Biosimilar Monoclonal Antibodies Market Size Analysis (2020-2032)
1.5 Biosimilar Monoclonal Antibodies Market Development Status and Trends
1.5.1 Biosimilar Monoclonal Antibodies Industry Development Status Analysis
1.5.2 Biosimilar Monoclonal Antibodies Industry Development Trends Analysis
2 Biosimilar Monoclonal Antibodies Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Biosimilar Monoclonal Antibodies Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions
4.1 Biosimilar Monoclonal Antibodies Overall Market: 2024 VS 2025 VS 2032
4.2 Global Biosimilar Monoclonal Antibodies Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2020-2025)
4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2026-2032)
5 Global Biosimilar Monoclonal Antibodies Market Size by Type and Application
5.1 Global Biosimilar Monoclonal Antibodies Market Size by Type (2020-2032)
5.2 Global Biosimilar Monoclonal Antibodies Market Size by Application (2020-2032)
6 North America
6.1 North America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Biosimilar Monoclonal Antibodies Market Size by Type
6.4 North America Biosimilar Monoclonal Antibodies Market Size by Application
6.5 North America Biosimilar Monoclonal Antibodies Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Type
7.4 Europe Biosimilar Monoclonal Antibodies Market Size by Application
7.5 Europe Biosimilar Monoclonal Antibodies Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Biosimilar Monoclonal Antibodies Market Size by Type
8.4 China Biosimilar Monoclonal Antibodies Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Type
9.4 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Application
9.5 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Biosimilar Monoclonal Antibodies Market Size by Type
10.4 Latin America Biosimilar Monoclonal Antibodies Market Size by Application
10.5 Latin America Biosimilar Monoclonal Antibodies Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Type
11.4 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Application
11.5 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Biosimilar Monoclonal Antibodies Market Revenue by Key Manufacturers (2021-2025)
12.2 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis and Market Dynamic
12.2.1 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Biocon
13.1.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Biocon Biosimilar Monoclonal Antibodies Product Portfolio
13.1.3 Biocon Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Accord Healthcare
13.2.1 Accord Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Accord Healthcare Biosimilar Monoclonal Antibodies Product Portfolio
13.2.3 Accord Healthcare Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 AET Biotech
13.3.1 AET Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 AET Biotech Biosimilar Monoclonal Antibodies Product Portfolio
13.3.3 AET Biotech Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Amgen
13.4.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Amgen Biosimilar Monoclonal Antibodies Product Portfolio
13.4.3 Amgen Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Celltrion
13.5.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio
13.5.3 Celltrion Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Reddy＇s Laboratories
13.6.1 Reddy＇s Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Reddy＇s Laboratories Biosimilar Monoclonal Antibodies Product Portfolio
13.6.3 Reddy＇s Laboratories Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Hospira
13.7.1 Hospira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Hospira Biosimilar Monoclonal Antibodies Product Portfolio
13.7.3 Hospira Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 3SBio
13.8.1 3SBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 3SBio Biosimilar Monoclonal Antibodies Product Portfolio
13.8.3 3SBio Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Allergan
13.9.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Allergan Biosimilar Monoclonal Antibodies Product Portfolio
13.9.3 Allergan Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Alvartis
13.10.1 Alvartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Alvartis Biosimilar Monoclonal Antibodies Product Portfolio
13.10.3 Alvartis Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis
14.2 Biosimilar Monoclonal Antibodies Industry Raw Material and Suppliers Analysis
14.2.1 Biosimilar Monoclonal Antibodies Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Biosimilar Monoclonal Antibodies Typical Downstream Customers
14.4 Biosimilar Monoclonal Antibodies Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us